SCHEMBL29577802

SCHEMBL29577802

COc1cc(OC)cc(-c2cc3c(Cl)nc(Cl)nc3cn2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.49
▸ RAB9A P51151 5/20 0.49
▸ CYP1A1 P04798 4/20 0.46
▸ CYP1B1 Q16678 4/20 0.46
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2E1 P05181 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C8 P10632 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP4B1 P13584 1/20 0.41
▸ CYP2B6 P20813 1/20 0.41
▸ CYP3A5 P20815 1/20 0.41
▸ CYP2A7 P20853 1/20 0.41
▸ CYP3A7 P24462 1/20 0.41
▸ CYP2F1 P24903 1/20 0.41
▸ CYP2C18 P33260 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CYP2J2 P51589 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20332207 1.00 NPC1 (0.49) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL29577437 0.86 NPC1 (0.47) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL20330977 0.86 NPC1 (0.47) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL29428742 0.79 NPC1 (0.59) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL20330972 0.79 NPC1 (0.59) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL31693066 0.75 SMN1; SMN2 (0.41) CYP1A2KDM4EALDH1A1SMN1; SMN2
SCHEMBL31648329 0.73 FGFR1 (0.40) CYP1A1CYP1B1CYP1A2CYP3A4CYP2D6
SCHEMBL20331733 0.73 NPC1 (0.51) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL20331057 0.71 NPC1 (0.69) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL857818 0.70 KDM4E (0.48) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-B1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF ABBISKO THERAPEUTICS CO LTD (CN) 2022-06-08 — — EP disclosed
Send feedback